NESYRGY 5mg / 5mg tablets medication leaflet

C07FB12 nebivolol + amlodipine • Cardiovascular system | Beta blocking agents, other combinations | Beta blocking agents and calcium channel blockers

The combination of nebivolol and amlodipine is used for the treatment of hypertension in adult patients. Nebivolol is a beta-blocker that reduces heart rate and dilates blood vessels, while amlodipine is a calcium channel blocker that relaxes blood vessels.

The medication is taken orally, as directed by a doctor, usually once daily. It is important for patients to follow the treatment regimen and undergo regular check-ups to monitor blood pressure.

Patients should be aware of potential side effects, such as dizziness, headaches, or peripheral edema. It is important to inform the doctor of any unusual symptoms.

Common side effects include dizziness, headaches, and peripheral edema. In rare cases, severe reactions such as bradycardia or heart failure may occur. Patients should be informed of these risks before use.

General data about NESYRGY 5mg / 5mg

Substance: nebivolol + amlodipine

Date of last drug list: 01-03-2025

Commercial code: W70914005

Concentration: 5mg / 5mg

Pharmaceutical form: tablets

Quantity: 90

Product type: generic

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

Manufacturer: SANECA PHARMACEUTICALS, A.S. - SLOVACIA

Holder: MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. - LUXEMBURG

Number: 15816/2025/05

Shelf life: 2 years

Concentrations available for nebivolol + amlodipine

5mg/10mg, 5mg/5mg